For his work creating new kinds of drug delivery techniques and bringing those technologies to patients, Mark Prausnitz is one of the new members of the National Academy of Medicine (NAM).

The Academy announced his election Oct. 21 alongside 99 others. Membership in NAM is considered one of the highest recognitions in health and medicine, reserved for those who’ve made major contributions to healthcare, medical sciences, and public health. The roster is small: only 2,400 or so individuals have been honored.

“It’s an honor to be elected to the National Academy of Medicine and have the work of our team at Georgia Tech recognized in this way,” said Prausnitz, Regents’ Professor and J. Erskine Love Jr. Chair in the School of Chemical and Biomolecular Engineering.

The Academy cited Prausnitz for innovating microneedle and other advanced drug delivery technologies. He also was honored for translating those methods and devices into clinical trials and products and founding companies to bring the advances to patients. NAM praised Prausnitz for “inspiring students to be creative and impactful engineers.”

Read the full story on the College of Engineering website.